甲状腺功能减退症处方治疗:医生特征的影响
该研究基于2017年美国甲状腺协会成员调查,向389名应答医生呈现13个理论甲减患者场景,要求从六种治疗方案中选择。多因素分析显示,北美执业医生更倾向于处方含三碘甲状腺原氨酸的疗法。
核心结论
- 医生特征影响甲减处方模式,北美执业医生更倾向于处方含三碘甲状腺原氨酸的疗法。
研究设计与样本
- 2017年调查美国甲状腺协会成员,389名应答者中93%为甲减患者处方治疗。
- 向医生呈现13个理论甲减患者场景,要求从六种治疗方案中选择。
- 采用重复测量逻辑回归分析,控制所有患者和医生特征。
临床怎么用
- 临床医生应意识到自身特征(如执业地区)可能影响甲减治疗决策。
- 在含三碘甲状腺原氨酸疗法的获益与风险尚未充分明确时,需关注医患互动中的处方偏好。
局限性
- 无法确定医生特征影响处方模式的具体原因(如患者相关经验、媒体曝光、制药公司影响、教育活动等)。
- 含三碘甲状腺原氨酸疗法的获益与风险尚未完全 documented。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Physician characteristics and perceptions and their effect on choice of therapies for patients with thyroid cancer have been well studied. Some data also exist about physician characteristics and prescribing treatment for subclinical hypothyroidism. The effect of physician characteristics on prescribing thyroid preparations for treating overt hypothyroidism is less studied. METHODS: Members of the American Thyroid Association were surveyed in 2017. Physicians were presented with 13 different theoretical patients with hypothyroidism and asked to choose among six therapeutic options, including levothyroxine, synthetic combination therapy, thyroid extract, and liothyronine monotherapy. The 13 patient scenarios incorporated parameters that potentially provide reasons for considering combination therapy (presence of symptoms, low serum triiodothyronine concentration, and documentation of deiodinase polymorphisms). Repeated-measures logistic regression analysis was performed to examine the prescribing of the various therapies. Data regarding the responding physicians were also collected. These data included number of years in practice, country of practice, and specialty. Multivariate repeated-measures logistic regression analysis of prescribing patterns was also conducted controlling for all patient and physician characteristics. RESULTS: Of the 389 survey respondents, 93% prescribed therapy for hypothyroidism. Fifty-three percent of respondents had been in practice for >20 years, and 23% had been in practice for 11-20 years. Sixty-four percent practiced in North America, and 18% practiced in Europe. Eight-six percent were endocrinologists, and 5% were surgeons. In multivariate analysis, physicians from North America were both more likely to prescribe any triiodothyronine-containing therapies (odds ratio [OR] = 1.8 [confidence interval (CI) 1.3-2.4]) and more likely to add liothyronine to levothyroxine therapy (OR = 1.9 [CI 1.2-2.9]). In addition, they were more likely to prescribe desiccated thyroid extract or liothyronine monotherapy (OR = 1.7 [CI 1.0-2.9]). CONCLUSIONS: A previous analysis of this survey showed that patient characteristics profoundly affect physician prescribing patterns. The current multivariate analysis shows that physician characteristics affect prescribing patterns. Whether this is due to impact upon physicians of patient-related experiences, media exposure, influence from pharmaceutical companies, educational activities, or other concerns cannot be determined. However, these results have potential importance for understanding physician-patient interactions at a time when the benefits and risks of triiodothyronine-containing therapies have not been fully documented.
引用
- Jonklaas J, Tefera E, Shara N, et al. Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics. Thyroid. 2018. PMID: 30375273. doi:10.1089/thy.2018.0369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。